Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Striatal Dopamine and Alcohol Risk

NCT00050219 is registered in ClinicalTrials.gov with National Institute on Alcohol Abuse and Alcoholism (NIAAA) as lead sponsor.

NCT NCT00050219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00050219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Striatal Dopamine and Alcohol Risk
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phase
Observational
Overall status
Completed
Start date
November 30, 2002
Completion date
September 30, 2004
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol consumption